Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $48.83 on CONMED Corporation (NASDAQ:CNMD) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $1.98 for the next fiscal and $N/A for underway quarter. Valuation Estimates Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of CONMED Corporation (NASDAQ:CNMD) stands at 61.83. Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For CONMED Corporation, the PEG ratio for coming 3-5 years is 2.27. Technical Analysis The technical analysis highlights that CONMED Corporation current price is trading $2.32 points away +5.04% from $45.97, which stands as the 50-day moving average of the firm. The stock’s 200-day MA is $41.69 and, for now, the stock price is trading $6.60 or +15.84% away from that point. The 52-week high of CONMED Corporation (NASDAQ:CNMD) was $58.32 while lowest point recorded in 52-week was $35.51. It implies if stock price makes a movement of over $-10.03, it will record a new 52-week high. In the case of $+35.99% points drop, it will touch a new 52-week low.
1 Chart Pattern Every Investor Should Know